Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (71-80 of 260) with videos related to

Pageof 26
Sort By:
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Blood|August 1, 1993
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietinR S Negrin, R Stein, J Vardiman, et al.
Blood|February 1, 1991
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purgingR S Negrin, H P Kiem, I G Schmidt-Wolf, et al.
The Journal of Experimental Medicine|July 1, 1991
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activityI G Schmidt-Wolf, R S Negrin, H P Kiem, et al.
Blood|May 15, 1996
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergyR S Negrin, R Stein, K Doherty, et al.
Immunological Reviews|June 1, 1997
Cellular immunotherapy and autologous transplantation for hematologic malignancyK A Margolin, R S Negrin, K K Wong, et al.
British Journal of Haematology|July 1, 1994
Propagation of large numbers of T cells with natural killer cell markersI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Experimental Hematology|December 26, 2001
Bioluminescence imaging of lymphocyte trafficking in vivoJ Hardy, M Edinger, M H Bachmann, et al.
Blood|January 18, 2011
CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDSuparna Dutt, Jeanette Baker, Holbrook E Kohrt, et al.
Blood|March 18, 2010
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effectsJanelle A Olson, Dennis B Leveson-Gower, Saar Gill, et al.
Pageof 26

Showing results (71-80 of 260) with videos related to

Sort By:
Pageof 26
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Blood|August 1, 1993
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietinR S Negrin, R Stein, J Vardiman, et al.
Blood|February 1, 1991
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purgingR S Negrin, H P Kiem, I G Schmidt-Wolf, et al.
The Journal of Experimental Medicine|July 1, 1991
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activityI G Schmidt-Wolf, R S Negrin, H P Kiem, et al.
Blood|May 15, 1996
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergyR S Negrin, R Stein, K Doherty, et al.
Immunological Reviews|June 1, 1997
Cellular immunotherapy and autologous transplantation for hematologic malignancyK A Margolin, R S Negrin, K K Wong, et al.
British Journal of Haematology|July 1, 1994
Propagation of large numbers of T cells with natural killer cell markersI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Experimental Hematology|December 26, 2001
Bioluminescence imaging of lymphocyte trafficking in vivoJ Hardy, M Edinger, M H Bachmann, et al.
Blood|January 18, 2011
CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDSuparna Dutt, Jeanette Baker, Holbrook E Kohrt, et al.
Blood|March 18, 2010
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effectsJanelle A Olson, Dennis B Leveson-Gower, Saar Gill, et al.
Pageof 26